Prognostic Effect of Ultra-Staging Node-Negative Colon Cancer Without Adjuvant Chemotherapy: A Prospective National Cancer Institute-Sponsored Clinical Trial

Journal of the American College of Surgeons

Volumn 221, Issue 3, 2015, Pages 643-651

  Protic, Mladjan ^a,b   Stojadinovic, Alexander ^c   Nissan, Aviram ^d   Wainberg, Zev ^e   Steele, Scott R ^f,g   Chen, David C ^e   Avital, Itzhak ^c   Bilchik, Anton J ^e,h,i  

^a Institute of Cardiovascular Disease   (Serbia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d SHEBA MEDICAL CENTER   (Israel)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MADIGAN ARMY MEDICAL CENTER   (United States)

^g UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^h JOHN WAYNE CANCER INSTITUTE   (United States)

ⁱ California Oncology Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; COLON ADENOCARCINOMA; COLON CANCER; COLON RESECTION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMATOXYLIN AND EOSIN STAINING; HEMICOLECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH ORGANIZATION; PRIMARY TUMOR; PRIORITY JOURNAL; RECTUM ANTERIOR RESECTION; RECTUM CANCER; STAINING; TOTAL COLON RESECTION; TRANSVERSE COLON; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; COLONIC NEOPLASMS; LYMPH NODE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84939563836     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2015.05.007     Document Type: Article

References (45)

1. L.A. Torre, F. Bray, R.L. Siegel, and et al. Global cancer statistics, 2012 CA Cancer J Clin 65 2015 87 108
2. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA Cancer J Clin 65 2015 5 29
3. G.M. Boland, G.J. Chang, A.B. Haynes, and et al. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer Cancer 119 2013 1593 1601
4. J.B. O'Connell, M.A. Maggard, and C.Y. Ko Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 96 2004 1420 1425
5. V.L. Tsikitis, D.L. Larson, B.G. Wolff, and et al. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved J Am Coll Surg 208 2009 42 47
6. M. Jessup, L. Gunderson, F. Green, and et al. 2010 Staging system for colon and rectal carcinoma Ann Surg Oncol 18 2011 1513 1517
7. K.D. Hong, S.I. Lee, and H.Y. Moon Lymph node ratio as determined by the 7th edition of the American Joint Committee on Cancer staging system predicts survival in stage III colon cancer J Surg Oncol 103 2011 406 410
8. D. Sargent, Q. Shi, G. Yothers, and et al. Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803 Eur J Cancer 47 2011 990 996
9. T. André, C. Boni, M. Navarro, and et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 2009 3109 3116
10. C.W.M. Van Gils, M. Koopman, L. Mol, and et al. Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands Acta Oncol 51 2012 57 64
11. R. Gray, J. Barnwell, C. McConkey, and et al. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study Lancet 370 2007 2020 2029
12. A. Jemal, F. Bray, M.M. Center, and et al. Global cancer statistics CA Cancer J Clin 61 2011 69 90
13. B.K. Edwards, E. Ward, B.A. Kohler, and et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates Cancer 116 2010 544 573
14. M. Donada, S. Bonin, R. Barbazza, and et al. Management of stage Ii colon cancer - the use of molecular biomarkers for adjuvant therapy decision BMC Gastroenterol 13 2013 36
15. A. Figueredo, M.E. Coombes, and S. Mukherjee Adjuvant therapy for completely resected stage II colon cancer Cochrane Database Syst Rev 2008 CD005390
16. A. Figueredo, M.L. Charette, J. Maroun, and et al. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group J Clin Oncol 22 2004 3395 3407
17. M. Morris, C. Platell, K. McCaul, and et al. Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting Int J Colorectal Dis 22 2007 887 895
18. N.N. Rahbari, U. Bork, E. Motschall, and et al. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis J Clin Oncol 30 2012 60 70
19. A. Stojadinovic, A. Nissan, M. Protic, and et al. Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01 Ann Surg 245 2007 846 857
20. A. Nissan, M. Protic, A.J. Bilchik, and et al. United States Military Cancer Institute Clinical Trials Group (USMCI GI-01) randomized controlled trial comparing targeted nodal assessment and ultrastaging with standard pathological evaluation for colon cancer Ann Surg 256 2012 412 427
21. K.F. Schulz, D.G. Altman, and D. Moher CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials Ann Intern Med 152 2010 726 732
22. H. Nelson, N. Petrelli, A. Carlin, and et al. Guidelines 2000 for colon and rectal cancer surgery J Natl Cancer Inst 93 2001 583 596
23. C. Mescoli, L. Albertoni, S. Pucciarelli, and et al. Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer J Clin Oncol 30 2012 965 971
24. G.J. Chang, M.A. Rodriguez-Bigas, J.M. Skibber, and et al. Lymph node evaluation and survival after curative resection of colon cancer: systematic review J Natl Cancer Inst 99 2007 433 441
25. L. Sobin, and C. Wittekind International Union Against Cancer (UICC). TNM classification of malignant tumors 6th ed 2002 Wiley New York
26. S. Edge, D. Byrd, and C. Compton Colon and rectum. AJCC Cancer Staging Manual 7th ed 2010 Springer New York 143 164
27. P.F. Engstrom, J.P. Arnoletti, A.B. Benson 3rd, and et al. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: colon cancer J Natl Compr Canc Netw 7 2009 778 831
28. N.S. Goldstein, W. Sanford, M. Coffey, and L.J. Layfield Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered Am J Clin Pathol 106 1996 209 216
29. N.S. Goldstein Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: recommendations for a minimum number of recovered lymph nodes based on predictive probabilities Am J Surg Pathol 26 2002 179 189
30. N.E. Joseph, E.R. Sigurdson, A.L. Hanlon, and et al. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection Ann Surg Oncol 10 2003 213 218
31. M. Gönen, D. Schrag, and M.R. Weiser Nodal staging score: a tool to assess adequate staging of node-negative colon cancer J Clin Oncol 27 2009 6166 6171
32. J.L. Marshall, D.G. Haller, A. de Gramont, and et al. Adjuvant therapy for stage II and III colon cancer: Consensus report of the International Society of Gastrointestinal Oncology Gastrointest Cancer Res 1 2007 146 154
33. S.H. Petersen, H. Harling, L.T. Kirkeby, and et al. Postoperative adjuvant chemotherapy in rectal cancer operated for cure Cochrane Database Syst Rev 3 2012 CD004078
34. J.S. Graham, and J. Cassidy Adjuvant therapy in colon cancer Expert Rev Anticancer Ther 12 2012 99 109
35. A. Stein, S. Hiemer, and H.-J. Schmoll Adjuvant therapy for early colon cancer: current status Drugs 71 2011 2257 2275
36. I.R.K. Bukholm, J. Bondi, P. Wiik, and et al. Presence of isolated tumour cells in mesenteric lymph nodes predicts poor prognosis in patients with stage II colon cancer Eur J Surg Oncol 29 2003 862 866
37. D.A.M. Sloothaak, S. Sahami, H.J. van der Zaag-Loonen, and et al. The prognostic value of micrometastases and isolated tumour cells in histologically negative lymph nodes of patients with colorectal cancer: a systematic review and meta-analysis Eur J Surg Oncol 40 2014 263 269
38. C.E. Bosch Roig, E. Roselló-Sastre, S. Alonso Hernández, and et al. Prognostic value of the detection of lymph node micrometastases in colon cancer Clin Transl Oncol 10 2008 572 578
39. A.J. Bilchik, D.S.B. Hoon, S. Saha, and et al. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial Ann Surg 246 2007 568 575 discussion 575-577
40. A. Oberg, R. Stenling, B. Tavelin, and G. Lindmark Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum 41 1998 1244 1249
41. G.J. Liefers, A.M. Cleton-Jansen, C.J. van de Velde, and et al. Micrometastases and survival in stage II colorectal cancer N Engl J Med 339 1998 223 228
42. A.E.H. Merrie, A.M. van Rij, E.R. Dennett, and et al. Prognostic significance of occult metastases in colon cancer Dis Colon Rectum 46 2003 221 231
43. A.E. Faerden, O.H. Sjo, I.R.K. Bukholm, and et al. Lymph node micrometastases and isolated tumor cells influence survival in stage I and II colon cancer Dis Colon Rectum 54 2011 200 206
44. A. Bilchik, A. Nissan, Z. Wainberg, and et al. Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials Ann Surg 252 2010 467 474 discussion 474-476
45. S. Sirop, M. Kanaan, A. Korant, and et al. Detection and prognostic impact of micrometastasis in colorectal cancer J Surg Oncol 103 2011 534 537